Immune response to vaccine adjuvants during the first year of life
about
Vaccinology in the third millennium: scientific and social challengesDeterminants of early life immune responses to RSV infectionContrasting Adult and Infant Immune Responses to HIV Infection and VaccinationHeterologous ("nonspecific") and sex-differential effects of vaccines: epidemiology, clinical trials, and emerging immunologic mechanismsOntogeny of early life immunityThe avian influenza vaccine Emerflu. Why did it fail?The ultra-potent and selective TLR8 agonist VTX-294 activates human newborn and adult leukocytes.Age-Related Gene Expression Differences in Monocytes from Human Neonates, Young Adults, and Older Adults.The Imidazoquinoline Toll-Like Receptor-7/8 Agonist Hybrid-2 Potently Induces Cytokine Production by Human Newborn and Adult Leukocytes.Variation between Populations in the Innate Immune Response to Vaccine Adjuvants.The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention.Listeria monocytogenes: a promising vehicle for neonatal vaccination.In vitro cytokine induction by TLR-activating vaccine adjuvants in human blood varies by age and adjuvant.Pediatric Vaccine Adjuvants: Components of the Modern Vaccinologist's ToolboxAdjuvant-induced Human Monocyte Secretome Profiles Reveal Adjuvant- and Age-specific Protein Signatures.Pattern recognition receptor-mediated cytokine response in infants across 4 continents.Age-dependent differences in systemic and cell-autonomous immunity to L. monocytogenes.Toll-like receptor 8 agonist nanoparticles mimic immunomodulating effects of the live BCG vaccine and enhance neonatal innate and adaptive immune responses.Age-Specific Adjuvant Synergy: Dual TLR7/8 and Mincle Activation of Human Newborn Dendritic Cells Enables Th1 Polarization.Early life immune ontogeny - understanding how we build and sustain immunity to infection.Is Infant Immunity Actively Suppressed or Immature?Identification and Characterization of Stimulator of Interferon Genes As a Robust Adjuvant Target for Early Life Immunization.Room Temperature Stable PspA-Based Nanovaccine Induces Protective Immunity.Neonatal Immunization: Rationale, Current State, and Future Prospects.
P2860
Q24261399-DCB98176-31A4-4292-9700-084628203E08Q26764790-EE274F5E-654F-4164-BCFF-E17A40773CFEQ26776518-0D737FBF-C882-4ED3-9DFC-3EEEE92B09A3Q26864779-E7406C70-A53F-4A3A-B24E-D378465249A9Q27000632-4EA98BD4-41A2-4A0C-9585-56D4E056B739Q30203302-389549CB-EA6E-44CC-BCEE-C055E624787CQ34618662-D1827A1E-09A5-4B53-81B7-BD22FA6B2C56Q35683728-EBE0298F-7BCA-42C3-9E76-2441BD0F7C25Q35746351-3998AAB3-41C4-4A92-AFFC-7982C04C4C78Q36733384-51AE2622-AA8B-47D9-B1B5-CE45234C1596Q36765590-DD521A60-D276-4E66-A2F9-A037D57133D5Q36977730-40CC6C01-6C1A-4807-883D-CEA5A200D3C6Q37001755-20958BFC-8F05-49D9-8077-12C198F8BED4Q37061084-916A1FEE-F576-41AF-80DF-86C759703CC1Q37372321-328684C3-5667-455F-8104-8392D3027C57Q37672021-4E4129A5-49AE-4C01-9725-1AEDA2EB654DQ38105072-2455C46B-EF6C-44EC-AFDB-6A341A2194A0Q40278311-D98A58F5-0013-4A62-9484-C8D1F782250CQ40468799-4BADDB13-1E75-4142-9D26-49B5A9D9C7F6Q40632570-AE3CBF09-71C0-48CA-AEB2-287853BF0BF7Q41646010-0C506953-729B-4B2A-AF5A-7DD0EACDE79DQ47169865-8EBF0BED-FF59-4677-B92C-3BA360B99132Q51732398-D0CC1EC8-4AD5-48B9-A795-1769861EF788Q52579157-76246F98-0F36-46BB-A1D9-8F25FA6B7BE2
P2860
Immune response to vaccine adjuvants during the first year of life
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Immune response to vaccine adjuvants during the first year of life
@ast
Immune response to vaccine adjuvants during the first year of life
@en
Immune response to vaccine adjuvants during the first year of life
@nl
type
label
Immune response to vaccine adjuvants during the first year of life
@ast
Immune response to vaccine adjuvants during the first year of life
@en
Immune response to vaccine adjuvants during the first year of life
@nl
prefLabel
Immune response to vaccine adjuvants during the first year of life
@ast
Immune response to vaccine adjuvants during the first year of life
@en
Immune response to vaccine adjuvants during the first year of life
@nl
P2860
P1433
P1476
Immune response to vaccine adjuvants during the first year of life
@en
P2093
P2860
P304
P356
10.1016/J.VACCINE.2012.10.016
P407
P577
2013-05-17T00:00:00Z